Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Apollo Medical (AMEH) stocks in Canada

Learn how to easily invest in Apollo Medical stocks.

Apollo Medical is a medical care facilities business based in the US. Apollo Medical stocks (AMEH.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $50.74 – an increase of 0.48% over the previous week. Apollo Medical employs 630 staff and has a trailing 12-month revenue of around $755.6 million.

How to buy shares in Apollo Medical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMEH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Apollo Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Apollo Medical's stock price?

Since the stock market crash in March caused by coronavirus, Apollo Medical's stock price has had significant positive movement.

Its last market close was $60.35, which is 71.02% up on its pre-crash value of $17.49 and 551.02% up on the lowest point reached during the March crash when the stocks fell as low as $9.27.

If you had bought $1,000 worth of Apollo Medical stocks at the start of February 2020, those stocks would have been worth $600.06 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $3,301.15.

Apollo Medical stock price (NASDAQ:AMEH)

Use our graph to track the performance of AMEH stocks over time.

Apollo Medical shares at a glance

Information last updated 2022-01-10.
Latest market close$60.35
52-week range$20.51 - $133.23
50-day moving average $82.71
200-day moving average $67.26
Wall St. target price$91.00
PE ratio 37.235
Dividend yield N/A (0%)
Earnings per share (TTM) $1.61

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Feature Table description
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks (total value up to $9,000) when you deposit and trade $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of at least $200/month. Valid until March 1, 2022.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Apollo Medical price performance over time

Historical closes compared with the close of $60.35 from 2022-01-14

1 week (2022-01-06) -2.54%
1 month (2021-12-16) -10.90%
3 months (2021-10-14) -14.95%
6 months (2021-07-16) -22.05%
1 year (2021-01-15) 178.50%
2 years (2020-01-16) 225.16%
3 years (2019-01-16) 218.47%
5 years (2017-01-13) 609.99%

Is Apollo Medical under- or over-valued?

Valuing Apollo Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Apollo Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Apollo Medical's P/E ratio

Apollo Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, Apollo Medical shares trade at around 37x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Apollo Medical's EBITDA

Apollo Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $139.3 million.

The EBITDA is a measure of a Apollo Medical's overall financial performance and is widely used to measure a its profitability.

Apollo Medical financials

Revenue TTM $755.6 million
Operating margin TTM 16.12%
Gross profit TTM $148 million
Return on assets TTM 9.03%
Return on equity TTM 16.98%
Profit margin 9.28%
Book value $9.82
Market capitalisation $3.3 billion

TTM: trailing 12 months

Apollo Medical share dividends

We're not expecting Apollo Medical to pay a dividend over the next 12 months.

Have Apollo Medical's shares ever split?

Apollo Medical's shares were split on a 1:10 basis on 26 April 2015. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Apollo Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Apollo Medical shares which in turn could have impacted Apollo Medical's share price.

Apollo Medical share price volatility

Over the last 12 months, Apollo Medical's shares have ranged in value from as little as $20.5103 up to $133.23. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Apollo Medical's is 0.1678. This would suggest that Apollo Medical's shares are less volatile than average (for this exchange).

Apollo Medical overview

Apollo Medical Holdings, Inc. , a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site